Key result
Apolipoprotein A-I enhanced the transport of newly synthesized cholesterol to cell-surface caveolae up to 5-fold compared to BSA in human skin fibroblasts.
Effect estimate: up to 5-fold enhancement
ApoA-I induces the transport of intracellular cholesterol to cell-surface caveolae in human skin fibroblasts, partly by stimulating caveolin expression.
Hypothesis-generating for ApoA-I in fibroblast cholesterol trafficking; leaves open in vivo relevance to atherosclerosis or HDL therapies.
We have studied the effect of lipid-free human plasma apolipoprotein A-I (apoA-I) on the transport of newly synthesized cholesterol to cell-surface cholesterol-rich domains, which in human skin fibroblasts are mainly represented by caveolae. Changes in transport of newly synthesized cholesterol were assessed after labelling cells with [(14)C]acetate at 15 degrees C and warming cells to permit the transfer of cholesterol, followed by the selective oxidation of cholesterol in cholesterol-rich domains (caveolae) in the plasma membrane before their partial purification. ApoA-I, but not BSA added in an equimolar concentration, enhanced the transport of cholesterol to the caveolae up to 5-fold in a dose- and time-dependent manner. The effect of apoA-I on cholesterol transport exceeded its effect on cholesterol efflux, resulting in an accumulation of intracellular cholesterol in caveolae. Methyl-beta-cyclodextrin, added at a concentration promoting cholesterol efflux to the same extent as apoA-I, also stimulated cholesterol trafficking, but was 3-fold less effective than apoA-I. Progesterone inhibited the transport of newly synthesized cholesterol to the caveolae. Treatment of cells with apoA-I stimulated the expression of caveolin, increasing the amount of caveolin protein and mRNA by approx. 2-fold. We conclude that apoA-I induces the transport of intracellular cholesterol to cell-surface caveolae, possibly in part through the stimulation of caveolin expression.
No takes yet. Share an insight, caveat, or question.
Sviridov et al. (2001) studied this question. Apolipoprotein A-I (apoA-I) vs. BSA was evaluated on Transport of newly synthesized cholesterol to cell-surface cholesterol-rich domains (caveolae) (up to 5-fold enhancement). Apolipoprotein A-I enhanced the transport of newly synthesized cholesterol to cell-surface caveolae up to 5-fold compared to BSA in human skin fibroblasts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: